معرفی
Matthew Grennan is an Associate Professor of Economics at Emory University, currently on leave from the Haas School of Business at the University of California, Berkeley. He holds the Robinson Chancellor’s Chair and co-directs the Robinson Life Science, Business, and Entrepreneurship Program. His academic journey includes prior faculty roles at Wharton and the University of Toronto, with a PhD from NYU Stern in Economics and Business Strategy.
Education:
- Ph.D., Strategy/Economics, New York University Stern School of Business (2010)
- M.S., Applied Economics, University of Minnesota (2005)
- B.S., Industrial Engineering, Iowa State University (2002)
Research Interests: Grennan focuses on competition, innovation, and healthcare markets. His work integrates empirical and theoretical models to analyze product development, pricing, and stakeholder value. Key areas include life sciences, medical technology, and health policy, with emphasis on antitrust, price transparency, and physician-industry relationships. His research has been published in top journals like the American Economic Review, Management Science, and Health Affairs.
Awards & Recognition:
- PURC Prize for Best Paper in Regulatory Economics (2018)
- Teaching awards from Berkeley, Wharton, Toronto, and Poets & Quants
Consulting & Expertise: Senior Consultant at Compass Lexecon, advising on antitrust, intellectual property, and healthcare litigation. Provides expert testimony for clients including the U.S. Department of Justice and major corporations. Advises startups and consults for firms like Medtronic, focusing on data-driven strategies and regulatory challenges.
Labs & Teams: Active in interdisciplinary programs linking life sciences, business, and entrepreneurship, particularly through the Robinson Program at Berkeley and Emory collaborations.
